| Tag | Content |
|---|
EnhancerAtlas ID | HS060-16666 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr19:3552490-3553530 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr19:3553048-3553069 | AATTGGGAAGTGAAACCAAAA | - | 6.03 | | IRF2 | MA0051.1 | chr19:3553052-3553070 | GGGAAGTGAAACCAAAAC | + | 7.12 | | Stat6 | MA0520.1 | chr19:3553085-3553100 | GTTTCTCTGGAACTA | - | 6.19 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_34560 | chr19:3552567-3553530 | HCT-116 | | SE_34690 | chr19:3552514-3576989 | HeLa |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAGACAGAGT CTCGCTCTGT TGCCCAGGCT GGAGTGCAGT GGTGCGATCT CAGCTCATTG 60
CAGCCTCTGC CTCCCTAGCT CAAGCCATTC TCCCACCTCA GCCTCCCGTG TAGCTGGGAT 120
TACAGGTACC TGCCGCCACA TCCCACCACA TCCAGCTAAT GTTTGTATTT TTGGTAGGGA 180
TGGGGTTTCA CCACGTTGGC CAGGCTGAAG TCGAACTCCT AGCCTCAAGT GATCCTCCTG 240
CCTCGGCCTC CCAAAGTGCT CGGATTACAG ACTTGAGCCA CCATACCGGC TGTTACTTCA 300
GTATCTTCTG AGTGAGTAAC AATAGTGGCC CTGACACAGC CTGTAAGCGT GGGTGTCATT 360
ATCCTCATTT TCCAGATGGG AAAATTGAGG CCCCTAGAGT GAGTCGGAGC CAGGCTCCTT 420
CCCTGCAGCC CTGCACTCCT CTCCTCCCAG CCTGGGGCAC CTGGAAGGGC CCCTGTACCA 480
AGCCTGGTGG CTGGACCTCC TTCCTCCCTC CGGAGGTGAC CTCATCCCCA GACCCTGGGC 540
CCGCCCCCAG AGAACTGGAA TTGGGAAGTG AAACCAAAAC CAGCCTCTCC TGCTGGTTTC 600
TCTGGAACTA GGGCCTGGGA GGGTTTGCGC AGATTCCTGG GGTCCTTGGG GAGGTCATCC 660
GGGGGCAGAG CATGAACTGT GGACTCCAGT GAGAAGGTCC CTTCCTGGCT GGACTCCCTG 720
TTCCTGCTGG CCAGTCTGGG TTAACCATTG TTGGGGCCAG GCTGCCTGGC CTGGGGACCT 780
CGGGCAAGTG ACTGTGCCTC TCTAGGCCTC AGTTTTCAGA AAACAGGGAT AGTGGCCAGG 840
AGTGGTGGAT CATGTAATCA ATCCCAGCAC TTTGGGAGGC TGAGGTGGGA GGACTGCTTG 900
AACCCAGGAG GTCGAGGCTG CAGTGAGTCG TGATCGTGCC ACTGCGCTCC AGCCTGGGCG 960
ACAGAGCGAG ACCCTGTCAA GAAAAAAAAA AAAAGGCCGG GCGCGGTGGC TCACGCCTGT 1020
AATCCCAGCA CTTTGGGAGA 1040
|
